<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Study registries offer the opportunity to evaluate the effects of new therapies or to observe the consequences of new treatments in clinical practice </plain></SENT>
<SENT sid="1" pm="."><plain>The SITS-MOST registry confirmed the validity of findings from randomized trials on intravenous thrombolysis concerning safety and efficacy in the clinical routine </plain></SENT>
<SENT sid="2" pm="."><plain>Current study registries concerning new interventional thrombectomy techniques suggest a high recanalization rate; however, the clinical benefit can only be evaluated in randomized, controlled trials </plain></SENT>
<SENT sid="3" pm="."><plain>Similarly, the experiences of the BASICS registry on basilar <z:mp ids='MP_0006134'>artery occlusion</z:mp> have led to the initiation of a controlled trial </plain></SENT>
<SENT sid="4" pm="."><plain>The benefit of hemicraniectomy in malignant <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> has been demonstrated by the pooled analysis of three randomized trials </plain></SENT>
<SENT sid="5" pm="."><plain>Numerous relevant aspects are currently documented in the DESTINY-R registry </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, the recently started RASUNOA registry examines diagnostic and therapeutic aspects of ischemic and hemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> occurring during therapy with new oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
</text></document>